Zimmer and ISTO decide to go separate ways with the tissue and cartilage technology

ISTO AND ZIMMER PART WAYS (Orthopedics This Week)
ISTO Technologies, Inc. and Zimmer Holdings, Inc. have reached a fork in the road. And they’re taking it.
On April 29, 2013, ISTO announced that the companies have called off their collaboration and will go their own ways to develop products to repair cartilage defects. ISTO is assuming full control of the DeNovo ET engineered tissue program. Zimmer will get ownership of DeNovo NT, a particulated juvenile cartilage allograft tissue implant product. ISTO is renaming DeNovo ET to RevaFlex.
We asked ISTO Chief Financial Officer Scott Gill why the ...